United States President Donald Trump on Thursday unveiled TrumpRx.gov, a website aimed at offering American consumers access to discounted medications and a central pillar of his efforts to reduce drug prices in the United States.
Trump announced the new site at a White House event alongside Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, and Joe Gebbia, director of the National Design Studio and co-founder of Airbnb.
“People will save a lot of money and stay healthy,” Trump said.
with the Trump administration to lower drug prices for Americans in exchange for exemptions from U.S. tariffs.
Under these agreements, they will lower prices for the government’s Medicaid program and, through TrumpRx, for consumers who pay in cash.
to drastically reduce the prices of popular GLP-1-based weight loss drugs. The government said these measures would reduce prices to an average of between $149 and $350 per month for Americans.
Currently, Novo and Lilly sell their weight loss drugs directly to consumers, representing more than 10% of total sales, according to the companies.
Novo’s Wegovy tablet, launched at the beginning of last month, is being sold exclusively through direct-to-consumer channels while the company waits for coverage terms to be defined by insurers.
“We continue to make it easier for people to access our authentic, FDA-approved medicines by expanding availability through multiple convenient options,” said Chris Pernie, Novo’s associate vice president of U.S. public affairs.
“The launch of TrumpRx will further expand patient access to Ozempic and Wegovy, including the newly approved Wegovy tablet, at our private pay prices,” Pernie said in a statement.
White House spokeswoman Karoline Leavitt said in an X post that the direct-to-consumer site would be “state-of-the-art” and “will save millions of Americans money.”
According to STAT News, the site will be operated by the drug discount platform GoodRx. The publication reported that TrumpRx will not sell the drugs directly, but will refer patients to other websites to purchase them.
It is not known for sure how much consumers will save. The site is aimed at consumers who want to purchase medications without using their health insurance, which means that most purchases will not count toward patients’ health insurance deductibles.
“There’s a real question about the value of this for people with health insurance,” said Juliette Cubanski, deputy director of Medicare policy at the health policy organization KFF. “In some cases, we may be talking about direct costs that are still relatively unaffordable for many people.”
Patients in the U.S. currently pay much more for prescription drugs, often nearly three times more than in other developed countries, and Trump has pressured drugmakers to reduce U.S. prices to levels charged abroad.
Other pharmaceutical companies that have signed the agreements include Pfizer, AstraZeneca, Merck and GSK.
In addition to obesity medications, medicines that will be available on the site include Merck’s diabetes drug Januvia; the anticoagulant Plavix, from Sanofi; the Advair Diskus 500/50 asthma inhaler, from GSK; Amgen’s cholesterol drug Repatha; and Gilead’s Epclusa hepatitis C treatment.
